Regen BioPharma, Inc. RGBP
0.00 USD 0.00 (-44.44%)
Regular-session close
0.0001 Day range 0.0001
0.00005 52-week range 0.014
- YTD
- -98.65%
- 1 year
- -98.90%
- Market cap
- 202.92K
- EPS (ttm)
- -0.02
- YTD return
- -98.65%
- 1-year return
- -98.90%
- Volume
- 2.50M
- Avg volume
- 6.43M
- Open
- 0.0001
- Previous close
- 0.00018
- Day's range
- 0.0001 – 0.0001
- 52-week range
- 0.00005 – 0.014
5D +0.000100 (+100.00%)
News
Regen BioPharma, Inc. Provides Shareholder Update on Company's Activities and Direction
Presenting on Emerging Growth Conference 88 Day 1 on December 10; Register to live stream
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.
Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time
Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024
Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program
Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023
Your note
Sign in to keep a note on RGBP — it syncs with the Stock Master app.
